JP2023534127A5 - - Google Patents
Info
- Publication number
- JP2023534127A5 JP2023534127A5 JP2022577551A JP2022577551A JP2023534127A5 JP 2023534127 A5 JP2023534127 A5 JP 2023534127A5 JP 2022577551 A JP2022577551 A JP 2022577551A JP 2022577551 A JP2022577551 A JP 2022577551A JP 2023534127 A5 JP2023534127 A5 JP 2023534127A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- seq
- alk4
- actriib
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040400P | 2020-06-17 | 2020-06-17 | |
| US63/040,400 | 2020-06-17 | ||
| US202163159003P | 2021-03-10 | 2021-03-10 | |
| US63/159,003 | 2021-03-10 | ||
| PCT/US2021/037557 WO2021257655A1 (en) | 2020-06-17 | 2021-06-16 | Actrii-alk4 antagonists and methods of treating heart failure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023534127A JP2023534127A (ja) | 2023-08-08 |
| JP2023534127A5 true JP2023534127A5 (https=) | 2024-06-25 |
Family
ID=79268368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577551A Pending JP2023534127A (ja) | 2020-06-17 | 2021-06-16 | ＡｃｔＲＩＩ－ＡＬＫ４アンタゴニストおよび心不全を処置する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240252628A1 (https=) |
| EP (1) | EP4168036A4 (https=) |
| JP (1) | JP2023534127A (https=) |
| KR (1) | KR20230025432A (https=) |
| CN (1) | CN116113440A (https=) |
| AU (1) | AU2021293908A1 (https=) |
| BR (1) | BR112022025473A2 (https=) |
| CA (1) | CA3182523A1 (https=) |
| MX (1) | MX2022016243A (https=) |
| WO (1) | WO2021257655A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102877920B1 (ko) | 2015-11-16 | 2025-10-30 | 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 | 티틴-기반 근증 및 다른 티틴성병증의 치료를 위한 물질 및 방법 |
| AR114350A1 (es) | 2018-01-31 | 2020-08-26 | Res Institute At Nationwide ChildrenS Hospital | Terapia genética para la distrofia muscular de cinturas del tipo 2c |
| KR20210028162A (ko) | 2018-06-29 | 2021-03-11 | 더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 | 지대근 이영양증 2a형을 치료하기 위한 재조합 아데노 연관 바이러스 생성물 및 방법 |
| AU2020229340A1 (en) | 2019-02-26 | 2021-09-16 | Research Institute At Nationwide Children's Hospital | Adeno-associated virus vector delivery of B-sarcoglycan and the treatment of muscular dystrophy |
| RS65421B1 (sr) | 2019-08-21 | 2024-05-31 | Res Inst Nationwide Childrens Hospital | Isporuka adeno-asociranog virusnog vektora alfa-sarkoglikana i lečenje mišićne distrofije |
| WO2022192411A1 (en) * | 2021-03-10 | 2022-09-15 | Acceleron Pharma Inc. | Actrii-alk4 antagonists and methods of treating heart failure |
| JP2024511315A (ja) * | 2021-03-10 | 2024-03-13 | アクセルロン ファーマ インコーポレイテッド | Ａｃｔｒｉｉ－ａｌｋ４アンタゴニスト及び心不全の治療方法 |
| EP4219726A1 (en) * | 2021-10-15 | 2023-08-02 | Research Institute at Nationwide Children's Hospital | Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy |
| CN118671353A (zh) * | 2024-05-30 | 2024-09-20 | 中国人民解放军总医院第一医学中心 | 用于ais诊断的生物标志物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10358476B2 (en) * | 2015-04-06 | 2019-07-23 | Acceleron Pharma Inc. | Single arm type I and type II receptor fusion proteins and uses thereof |
| MA41919A (fr) * | 2015-04-06 | 2018-02-13 | Acceleron Pharma Inc | Hétéromultimères alk4:actriib et leurs utilisations |
| DK3496739T3 (da) * | 2016-07-15 | 2021-05-10 | Acceleron Pharma Inc | Sammensætninger omfattende actriia-polypeptider til brug i behandlingen af pulmonal hypertension |
| CA3039573A1 (en) * | 2016-10-05 | 2018-04-12 | Acceleron Pharma Inc. | Alk4:actriib heteromultimers and uses thereof |
| WO2018187209A1 (en) * | 2017-04-03 | 2018-10-11 | Acceleron Pharma Inc. | Compositions and methods for treating spinal muscular atrophy |
-
2021
- 2021-06-16 JP JP2022577551A patent/JP2023534127A/ja active Pending
- 2021-06-16 WO PCT/US2021/037557 patent/WO2021257655A1/en not_active Ceased
- 2021-06-16 US US18/010,888 patent/US20240252628A1/en active Pending
- 2021-06-16 MX MX2022016243A patent/MX2022016243A/es unknown
- 2021-06-16 KR KR1020237000845A patent/KR20230025432A/ko active Pending
- 2021-06-16 BR BR112022025473A patent/BR112022025473A2/pt unknown
- 2021-06-16 AU AU2021293908A patent/AU2021293908A1/en active Pending
- 2021-06-16 CA CA3182523A patent/CA3182523A1/en active Pending
- 2021-06-16 CN CN202180056305.2A patent/CN116113440A/zh active Pending
- 2021-06-16 EP EP21826739.1A patent/EP4168036A4/en active Pending